{"id":"improved-opioid-tapering-instructions","safety":{"commonSideEffects":[{"rate":null,"effect":"Withdrawal symptoms (anxiety, insomnia, muscle aches)"},{"rate":null,"effect":"Pain exacerbation during tapering"},{"rate":null,"effect":"Psychological distress"}]},"_chembl":{"chemblId":"CHEMBL440626","moleculeType":"Small molecule","molecularWeight":"1268.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Improved Opioid-Tapering Instructions represent a standardized clinical management protocol developed by Brigham and Women's Hospital to guide healthcare providers in gradually reducing opioid medications in patients. This is a behavioral/clinical intervention tool rather than a pharmacological agent with a specific molecular target or mechanism of action.","oneSentence":"This is a clinical protocol or instructional guideline for safely reducing opioid doses in patients, not a pharmaceutical drug with a molecular mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:48:18.835Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Opioid dose reduction and discontinuation in patients on chronic opioid therapy"}]},"trialDetails":[{"nctId":"NCT05821699","phase":"NA","title":"Effect of Personalized Pain Coaches After Orthopaedic Surgery for Patients With Sports Medicine Injuries","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-08-17","conditions":"Sports Medicine Injuries","enrollment":150},{"nctId":"NCT03534102","phase":"PHASE4","title":"Can Simplified and More Detailed Instructions Affect Post-Operative Narcotic Consumption","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2022-06-06","conditions":"Opioid Use, Opioid Dependence, Knee Pain Chronic","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Improved Opioid-Tapering Instructions","genericName":"Improved Opioid-Tapering Instructions","companyName":"Brigham and Women's Hospital","companyId":"brigham-and-women-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a clinical protocol or instructional guideline for safely reducing opioid doses in patients, not a pharmaceutical drug with a molecular mechanism. Used for Opioid dose reduction and discontinuation in patients on chronic opioid therapy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}